Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth I Ataga

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
Blood|January 12, 2008
Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell diseaseAllison E Ashley-Koch, Laine Elliott, Melanie E Kail, et al.
Journal of Hematology & Oncology|February 19, 2013
A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell diseaseTed Wun, Denis Soulieres, Andrew L Frelinger, et al.
The New England Journal of Medicine|December 14, 2016
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell DiseaseKenneth I Ataga, Abdullah Kutlar, Julie Kanter, et al.
Blood|April 7, 2019
Red blood cells modulate structure and dynamics of venous clot formation in sickle cell diseaseCamille Faes, Anton Ilich, Amandine Sotiaux, et al.
Blood Advances|December 4, 2019
American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney diseaseRobert I Liem, Sophie Lanzkron, Thomas D Coates, et al.
Blood Advances|November 15, 2018
Prevalence of inherited blood disorders and associations with malaria and anemia in Malawian childrenPatrick T McGann, Anne M Williams, Graham Ellis, et al.
British Journal of Haematology|April 3, 2012
Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE)Lori Styles, Carrie G Wager, Richard J Labotka, et al.
Clinical Trials (London, England)|March 30, 2013
IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studiesCarlton D Dampier, Wally R Smith, Carrie G Wager, et al.
British Journal of Haematology|September 4, 2024
Association of biomarkers of endothelial function, coagulation activation and kidney injury with persistent albuminuria in sickle cell anaemiaLaila Elsherif, Yihan Tang, Kammie L Patillo, et al.
The New England Journal of Medicine|June 15, 2019
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell DiseaseElliott Vichinsky, Carolyn C Hoppe, Kenneth I Ataga, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Blood|January 12, 2008
Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell diseaseAllison E Ashley-Koch, Laine Elliott, Melanie E Kail, et al.
Journal of Hematology & Oncology|February 19, 2013
A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell diseaseTed Wun, Denis Soulieres, Andrew L Frelinger, et al.
The New England Journal of Medicine|December 14, 2016
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell DiseaseKenneth I Ataga, Abdullah Kutlar, Julie Kanter, et al.
Blood|April 7, 2019
Red blood cells modulate structure and dynamics of venous clot formation in sickle cell diseaseCamille Faes, Anton Ilich, Amandine Sotiaux, et al.
Blood Advances|December 4, 2019
American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney diseaseRobert I Liem, Sophie Lanzkron, Thomas D Coates, et al.
Blood Advances|November 15, 2018
Prevalence of inherited blood disorders and associations with malaria and anemia in Malawian childrenPatrick T McGann, Anne M Williams, Graham Ellis, et al.
British Journal of Haematology|April 3, 2012
Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE)Lori Styles, Carrie G Wager, Richard J Labotka, et al.
Clinical Trials (London, England)|March 30, 2013
IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studiesCarlton D Dampier, Wally R Smith, Carrie G Wager, et al.
British Journal of Haematology|September 4, 2024
Association of biomarkers of endothelial function, coagulation activation and kidney injury with persistent albuminuria in sickle cell anaemiaLaila Elsherif, Yihan Tang, Kammie L Patillo, et al.
The New England Journal of Medicine|June 15, 2019
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell DiseaseElliott Vichinsky, Carolyn C Hoppe, Kenneth I Ataga, et al.
Pageof 14